Dr. Hammers on the CheckMate-214 Study for RCC

Описание к видео Dr. Hammers on the CheckMate-214 Study for RCC

Hans Hammers, MD, PhD, associate professor, Internal Medicine, UT Southwestern Medical Center, discusses the CheckMate-214 study for patients with renal cell carcinoma (RCC).

Комментарии

Информация по комментариям в разработке